Literature DB >> 21947415

C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia.

Jaime Haidet1, Vincenza Cifarelli, Massimo Trucco, Patrizia Luppi.   

Abstract

OBJECTIVE: We investigated C-peptide effects on inflammatory cytokine release and adhesion of monocytes exposed to high glucose and lipopolysaccharide (LPS) in vitro.
MATERIALS AND METHODS: Monocytic cells (U-937) were cultured in the presence of 30 mmol/L glucose and stimulated with 0.5 ng/μL LPS in the presence or absence of C-peptide (1 μmol/L) for 24 h to induce inflammatory cytokine secretion. Adhesion of U-937 monocytes to human aortic endothelial cells (HAEC) was also studied in the presence or absence of C-peptide. Concentrations of IL-6, IL-8, macrophage inflammatory protein(MIP)-1α, and MIP-1β in supernatants from LPS-stimulated U-937 monocytes were assessed by Luminex. To gain insights into potential intracellular signaling pathways affected by C-peptide, we investigated nuclear translocation of nuclear factor(NF)-κB p65/p50 subunits by western blot in LPS-treated U-937 cells. The effect of C-peptide on LPS-induced phosphorylation of the cytoplasmic protein IκB-α was also investigated by immunoblotting.
RESULTS: Addition of C-peptide significantly reduced cytokine secretion from LPS-stimulated U-937 monocytes. Adhesion of U-937 cells to HAEC was also significantly reduced by C-peptide. These effects were accompanied by reduced NF-κB p65/p50 nuclear translocation and decreased phosphorylation of IκB-α.
CONCLUSIONS: We conclude that, in conditions of hyperglycemia, C-peptide reduces monocytes activation via inhibition of the NF-κB pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947415     DOI: 10.1007/s00011-011-0384-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  43 in total

Review 1.  Update on transplanting beta cells for reversing type 1 diabetes.

Authors:  R Paul Robertson
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

2.  In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction.

Authors:  R Morishita; T Sugimoto; M Aoki; I Kida; N Tomita; A Moriguchi; K Maeda; Y Sawa; Y Kaneda; J Higaki; T Ogihara
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

3.  Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children.

Authors:  A B Erbağci; M Tarakçioğlu; Y Coşkun; E Sivasli; E Sibel Namiduru
Journal:  Clin Biochem       Date:  2001-11       Impact factor: 3.281

Review 4.  Long-term complications of diabetes mellitus.

Authors:  D M Nathan
Journal:  N Engl J Med       Date:  1993-06-10       Impact factor: 91.245

5.  C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion.

Authors:  L H Young; Y Ikeda; R Scalia; A M Lefer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-10       Impact factor: 4.733

6.  The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats.

Authors:  Anders A F Sima; Zhen-guo Li
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

7.  Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction.

Authors:  Casper G Schalkwijk; Piet M Ter Wee; Coen D A Stehouwer
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

8.  Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells.

Authors:  Vincenza Cifarelli; Patrizia Luppi; Hubert M Tse; Jing He; Jon Piganelli; Massimo Trucco
Journal:  Atherosclerosis       Date:  2008-02-21       Impact factor: 5.162

9.  Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation.

Authors:  Brian S Zuckerbraun; Carol A McCloskey; Raja S Mahidhara; Peter K M Kim; Bradley S Taylor; Edith Tzeng
Journal:  J Vasc Surg       Date:  2003-10       Impact factor: 4.268

10.  Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients.

Authors:  Francesco Panero; Giulia Novelli; Chiara Zucco; Paolo Fornengo; Massimo Perotto; Olivia Segre; Giorgio Grassi; Paolo Cavallo-Perin; Graziella Bruno
Journal:  Diabetes Care       Date:  2008-11-18       Impact factor: 17.152

View more
  12 in total

1.  Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats.

Authors:  Azizul Haque; Mollie Capone; Denise Matzelle; April Cox; Naren L Banik
Journal:  Neurochem Res       Date:  2017-05-15       Impact factor: 3.996

Review 2.  C-Peptide and its career from innocent bystander to active player in diabetic atherogenesis.

Authors:  Corinna Lebherz; Nikolaus Marx
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

Review 3.  Insights into the physiology of C-peptide.

Authors:  D Vejrazkova; M Vankova; P Lukasova; J Vcelak; B Bendlova
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

4.  Relationship Between C-Reactive Protein and Respiratory Diseases in Patients with Type 2 Diabetic Retinopathy.

Authors:  Kejia Chen; Jiamin Yan; Ling Wu; Xingbo Gu
Journal:  Med Sci Monit       Date:  2022-05-17

5.  Combined zinc supplementation with proinsulin C-peptide treatment decreases the inflammatory response and mortality in murine polymicrobial sepsis.

Authors:  Siarhei Slinko; Giovanna Piraino; Paul W Hake; John R Ledford; Michael O'Connor; Patrick Lahni; Patrick D Solan; Hector R Wong; Basilia Zingarelli
Journal:  Shock       Date:  2014-04       Impact factor: 3.454

6.  Paradoxical Pro-inflammatory Responses by Human Macrophages to an Amoebae Host-Adapted Legionella Effector.

Authors:  Christopher Price; Snake Jones; Mirna Mihelcic; Marina Santic; Yousef Abu Kwaik
Journal:  Cell Host Microbe       Date:  2020-03-27       Impact factor: 21.023

Review 7.  Physiological effects and therapeutic potential of proinsulin C-peptide.

Authors:  Gina L C Yosten; Christine Maric-Bilkan; Patrizia Luppi; John Wahren
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-23       Impact factor: 4.310

Review 8.  The clinical potential of C-peptide replacement in type 1 diabetes.

Authors:  John Wahren; Asa Kallas; Anders A F Sima
Journal:  Diabetes       Date:  2012-04       Impact factor: 9.461

9.  Initiation of Pancreatic Cancer: The Interplay of Hyperglycemia and Macrophages Promotes the Acquisition of Malignancy-Associated Properties in Pancreatic Ductal Epithelial Cells.

Authors:  Lilli Otto; Sascha Rahn; Tina Daunke; Frederik Walter; Elsa Winter; Julia Luisa Möller; Stefan Rose-John; Daniela Wesch; Heiner Schäfer; Susanne Sebens
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

Review 10.  Stress hyperglycemia, insulin treatment, and innate immune cells.

Authors:  Fangming Xiu; Mile Stanojcic; Li Diao; Marc G Jeschke
Journal:  Int J Endocrinol       Date:  2014-05-08       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.